XXXXXX- Xenon & Neural Inertia
Recruiting
99 years or below
All
Phase
N/A
20 participants needed
Brief description of study
This pilot study involves the administration of xenon gas via the ENHANCER 3000 delivery system to 12 healthy adult volunteers; xenon concentrations will range from 0% to up to 75%. Subjects will wear an Actiwatch for 7 days and nights prior to xenon administration (Study Day) and 7 days/nights afterwards. Subjects will also undergo neurocognitive testing. They will undergo a series of head CTs before, during, and after xenon administration. The initial CT is a full-coverage CT, but subsequent scans will be limited to 3-slice acquisitions.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Neurocognitive Dysfunction
-
Age: 99 years or below
-
Gender: All
Updated on
19 Feb 2024.
Study ID: 824229
Find a site
,
Your Information has been sent successfully.
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up
Send a message
Enter your contact details to connect with study team
Primary Contact
Message For Non Enrolling By Invitation Trial
Select a study center that’s convenient for you, and get in touch with the study team.
Please choose between Voice or SMS based delivery of verification code
or